VNN1 Antikörper (AA 151-250) (Cy3)
Kurzübersicht für VNN1 Antikörper (AA 151-250) (Cy3) (ABIN6983183)
Target
Alle VNN1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-250
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Cow,Sheep,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human VNN1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- VNN1 (Vanin 1 (VNN1))
-
Andere Bezeichnung
- VNN1
-
Hintergrund
-
Synonyms: HDLCQ8, High density lipoprotein cholesterol level quantitative trait locus 8, included, Pantetheinase, Pantetheine hydrolase, Tiff66, V-1 antibody Vanin 1, Vanin-1, Vannin 1, Vascular non inflammatory molecule 1, Vascular non-inflammatory molecule 1, VNN 1, VNN1, VNN1_HUMAN.
Background: Amidohydrolase that hydrolyzes specifically one of the carboamide linkages in D-pantetheine thus recycling pantothenic acid (vitamin B5) and releasing cysteamine.
-
Gen-ID
- 8876
-
UniProt
- O95497
-
Pathways
- Negative Regulation of intrinsic apoptotic Signaling
Target
-